2030 Pharmaceutical Companies Pharmaceutical Manufacturing 
European Pharmaceutical Review
JULY 18, 2023
According to the research, the pharmaceutical quality management systems market is projected to reach $3.97 billion by 2030. Adoption of QMS within pharma and biopharma is increasing due to strict regulations, frequent changes in the manufacturing process and higher demand to increase production capacity.
European Pharmaceutical Review
JUNE 10, 2024
The first industrial-scale pharmaceutical manufacturing facility for production of lead-212-based radioligand therapies has been inaugurated. The company hopes to produce this number tenfold by the end of 2030. billion.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Express Pharma
JUNE 14, 2024
India’s pharmaceutical industry is a global powerhouse. It is already a massive $50 billion market and is projected to grow to $130 billion by 2030. The manufacturing process and cost structure of this sector make it a prime candidate for early inclusion in this form of climate action.
European Pharmaceutical Review
DECEMBER 21, 2022
2 However, most of these efforts relating to catalysis, 3 process waste metrics, 4 lifecycle assessments, 5 pharmaceuticals in the environment 6 and the phase out of substances of concern 7 mainly mitigate the consequences of pharmaceutical manufacturing. So, when could the goal of a net zero pharmaceutical industry be achieved?
Expert insights. Personalized for you.
98 
Let's personalize your content